<DOC>
	<DOCNO>NCT02517463</DOCNO>
	<brief_summary>This prospective , open-label , single-drug , uncontrolled , observational clinical study . Women attend Family Planning Association Hong Kong ( FPAHK ) emergency contraception within 120 hour UPSI recruit . Subjects recruit Birth Control Clinics Youth Health Care Centres FPAHK . Depending time relation ovulation current menstrual cycle time presentation , woman classify two group : Group 1 : pre-ovulatory Group 2 : post-ovulatory After counsel obtain informed consent , eligible subject receive single dose ulipristal acetate 30 mg ( ellaOneÂ® ) direct supervision . A baseline blood test hormonal profile ( LH , oestradiol progesterone ) ultrasound scan ovarian follicle assessment carry designated doctor research nurse clinic visit . The subject advise act coitus return menstruation . They give diary chart record vaginal spot bleeding , possible side effect act intercourse , , contraceptive method use . A follow-up appointment arrange 1-2 week expect next menstruation . Any event unplanned pregnancy adverse effect record analysis .</brief_summary>
	<brief_title>Ulipristal Emergency Contraception Used Before After Ovulation</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<criteria>1 . Healthy woman age 18 year ; 2 . Regular menstrual cycle ( every 2135 day ) within past three cycle ; 3 . Requesting emergency contraception within 120 h single act unprotected intercourse current menstrual cycle ; 4 . Willing abstain act unprotected intercourse ; 5 . Available followup next 6 week 1 . Postabortion postpartum patient whose period yet return 2 . Regular use prescription drug admission study 3 . Intercourse treatment cycle 120 h admission study . 4 . Found pregnant time presentation 5 . Breastfeeding woman 6 . Women sterilize ( partner sterilize ) intrauterine contraceptive device insitu 7 . Uncertain date last menstrual period 8 . Women use hormonal contraceptive current past one cycle</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Emergency contraception</keyword>
	<keyword>ulipristal acetate</keyword>
	<keyword>efficacy</keyword>
</DOC>